Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pediatrix Medical (MD) Shares Outstanding (2016 - 2026)

Pediatrix Medical (MD) has disclosed Shares Outstanding for 17 consecutive years, with $83.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 3.37% to $83.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $83.0 million through Dec 2025, down 3.37% year-over-year, with the annual reading at $83.0 million for FY2025, 3.37% down from the prior year.
  • Shares Outstanding for Q4 2025 was $83.0 million at Pediatrix Medical, down from $85.8 million in the prior quarter.
  • The five-year high for Shares Outstanding was $87.2 million in Q1 2022, with the low at $82.9 million in Q4 2022.
  • Average Shares Outstanding over 5 years is $85.0 million, with a median of $85.7 million recorded in 2021.
  • The sharpest move saw Shares Outstanding dropped 4.07% in 2023, then grew 2.31% in 2024.
  • Over 5 years, Shares Outstanding stood at $86.4 million in 2021, then fell by 4.02% to $82.9 million in 2022, then rose by 1.29% to $84.0 million in 2023, then increased by 2.2% to $85.9 million in 2024, then dropped by 3.37% to $83.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $83.0 million, $85.8 million, and $86.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.